Can a simple sugar test spot acromegaly better?
NCT ID NCT04066569
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a standard glucose tolerance test (drinking a sugary solution) can reliably diagnose acromegaly, a condition caused by too much growth hormone. Researchers tested 109 people, some with acromegaly and some without, giving them two glucose tests and one placebo drink. The goal was to see if the test results were consistent and useful for diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Glucose drink (75 g) and placebo (aspartame drink)
- What this could lead to
- If successful, this could improve the accuracy and reliability of diagnosing acromegaly, leading to earlier and more precise detection.
- What could go wrong
- This is a small, completed study focused on test reproducibility, not treatment. Results may not change current diagnostic practices or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP, Bicêtre Hospital
Le Kremlin-Bicêtre, 94275, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Growth-Hormone blocker stay safe in everyday use? a korean study investigates
- Which intubation method works best for acromegaly patients?
- New octreotide pill faces off against current capsule in healthy volunteer study
- New software could improve acromegaly care
- New drug MAR002 aims to tame acromegaly in early trial
- Scientists hunt for hidden genes behind pituitary tumors